| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f83a4c82797355bcd55b0a4a252049b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3873abaff397acbfffa1595a12cfef41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cae9bfd601506f1faf546d54deebe5f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a1090f6f181adea775cbcdfd6bc3071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd656439ab15d45443c6dc65a2ca298f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59c6a921f33fe0adc58c2b6177184515 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2602-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-54 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-60 |
| filingDate |
2010-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_104b31021073eba2997da15149da0333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2160256f5ea9f5d93e5f72380a7d09f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0569b1da865bb8dbedc59cb5ece7f311 |
| publicationDate |
2011-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8058310-B2 |
| titleOfInvention |
Polyphenol proteasome inhibitors, synthesis, and methods of use |
| abstract |
The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present invention is also directed to pharmaceutical compositions useful in methods of inhibiting proteasomes and of treating cancers. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9399631-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014378541-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014045931-A1 |
| priorityDate |
2003-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |